Stock listing
NASDAQ:DNDN Dendreon Corp Stock
Follow Dendreon Corp into a list and get an email when it puts out news.
Delisted NASDAQ:DNDN no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:DNDN
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Dendreon Corp on 6ix
- Decks
- 4 decks · latest May 1, 2009
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Technical Presentation (May 2009) | Technical | 17 slides | May 1, 2009 |
| Merger or Acquisition (July 2003) | Merger or acquisition | 39 slides | Jul 7, 2003 |
| Merger or Acquisition (June 2003) | Merger or acquisition | 14 slides | Jun 10, 2003 |
| Merger or Acquisition (April 2003) | Merger or acquisition | 42 slides | Apr 15, 2003 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Pedro P Granadillo Other companies: Rocket Pharmaceuticals, Inc. (Director · Since at least Jan 4, 2018); Orchestra BioMed Holdings, Inc. (Director · Aug 3, 2020 – Aug 3, 2020 · Past); Immunovant, Inc. (Director · May 9, 2019 – May 9, 2019 · Past); NPS Pharmaceuticals Inc (Director · Nov 17, 2010 – Feb 21, 2015 · Past); Capricor Therapeutics, Inc. (Director · Oct 16, 2007 – May 10, 2011 · Past); Haemonetics Corporation (Director · May 5, 2006 – Nov 8, 2018 · Past); First Indiana Corp (Director · Jan 3, 2006 – Jan 2, 2008 · Past) | Director · Oct 7, 2009 – Jan 3, 2014 · Past |
| David Stump Other companies: Regenxbio Inc. (Independent Board Member · Since at least Oct 14, 2015); MacroGenics, Inc. (Director · Since at least Oct 9, 2013); Portola Pharmaceuticals Inc (Director · Sep 24, 2015 – Jul 2, 2020 · Past); Sunesis Pharmaceuticals Inc (Director · Jun 18, 2009 – Jun 30, 2020 · Past); Human Genome Sciences Inc (Exec. Vice President · Mar 10, 2009 – Jul 30, 2012 · Past) | Director · Jun 2, 2010 – Jan 3, 2014 · Past |
| Douglas G Watson Other companies: Delcath Systems, Inc. (Director · Jul 12, 2010 – Jul 10, 2014 · Past); Biomimetic Therapeutics Inc (Director · May 9, 2006 – Mar 1, 2013 · Past); Engelhard Corp (Director · Mar 15, 2006 – Jun 9, 2006 · Past); OraSure Technologies, Inc. (Director · Jan 23, 2006 – Nov 13, 2016 · Past) | Director · Jun 8, 2006 – Jan 3, 2014 · Past |
| Christine Mikail Cvijic Other companies: Neurogene Inc. (President and CFO, Director · Since at least Dec 18, 2023); Sio Gene Therapies Inc (Chief Admin Officer and GC · Jun 10, 2015 – Apr 29, 2016 · Past); NPS Pharmaceuticals Inc (SVP, Legal Affairs & GC · Mar 3, 2014 – Feb 21, 2015 · Past) | EVP, Corp Dev, Gen Cnsl/Scrtry · Feb 29, 2012 – Feb 10, 2014 · Past |
| Andrew Sandler M.D. Other companies: Dermata Therapeutics, Inc. (Director · Since at least Aug 12, 2021); Alpine Immune Sciences Inc (Chief Medical Officer · Aug 17, 2022 – Jan 5, 2023 · Past) | EVP, Chief Medical Officer · Jan 13, 2014 – Feb 13, 2015 · Past |
| Mark W. Frohlich Other companies: Rigel Pharmaceuticals, Inc. (Director · Since at least Mar 6, 2025); Juno Therapeutics Inc (See Remarks · Dec 18, 2014 – Feb 29, 2016 · Past) | EVP, R&D and CMO · Apr 3, 2013 – Jan 20, 2014 · Past |
| David Urdal | Director · Apr 30, 2010 – Jan 3, 2014 · Past |
| W Thomas Amick | Pres & Chief Executive Officer, Director · Jul 28, 2014 – Jul 31, 2014 · Past |
Log in to ask 6ix AI your own questions about Dendreon Corp.